404 related articles for article (PubMed ID: 20217053)
21. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
Pitsikas N; Markou A
Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
[TBL] [Abstract][Full Text] [Related]
22. Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence.
Hao Y; Martin-Fardon R; Weiss F
Biol Psychiatry; 2010 Aug; 68(3):240-8. PubMed ID: 20416862
[TBL] [Abstract][Full Text] [Related]
23. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of toluene-induced brain stimulation reward enhancement and behavioral disturbances by N-acetylcysteine in mice.
Wu CY; Tsai YL; Hsieh CP; Wang TC; Chan MH; Chen HH
Toxicology; 2018 Sep; 408():39-45. PubMed ID: 29935984
[TBL] [Abstract][Full Text] [Related]
25. The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity.
Henry SA; Lehmann-Masten V; Gasparini F; Geyer MA; Markou A
Neuropharmacology; 2002 Dec; 43(8):1199-209. PubMed ID: 12527469
[TBL] [Abstract][Full Text] [Related]
26. Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density.
Wolf R; Paelchen K; Matzke K; Dobrowolny H; Bogerts B; Schwegler H
Psychopharmacology (Berl); 2007 Sep; 194(1):93-102. PubMed ID: 17541558
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
28. Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats.
Grauer SM; Marquis KL
Psychopharmacology (Berl); 1999 Feb; 141(4):405-12. PubMed ID: 10090648
[TBL] [Abstract][Full Text] [Related]
29. The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats.
Bellesi M; Conti F
Neuropsychopharmacology; 2010 May; 35(6):1253-60. PubMed ID: 20072121
[TBL] [Abstract][Full Text] [Related]
30. Influence of metabotropic glutamate receptor agonists on the inhibitory effects of adenosine A1 receptor activation in the rat hippocampus.
de Mendonça A; Ribeiro JA
Br J Pharmacol; 1997 Aug; 121(8):1541-8. PubMed ID: 9283686
[TBL] [Abstract][Full Text] [Related]
31. The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior.
Kinney GG; Sur C; Burno M; Mallorga PJ; Williams JB; Figueroa DJ; Wittmann M; Lemaire W; Conn PJ
J Neurosci; 2003 Aug; 23(20):7586-91. PubMed ID: 12930797
[TBL] [Abstract][Full Text] [Related]
32. Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex.
Depoortere R; Perrault G; Sanger DJ
Behav Pharmacol; 1999 Feb; 10(1):51-62. PubMed ID: 10780302
[TBL] [Abstract][Full Text] [Related]
33. Presynaptic inhibition of corticothalamic feedback by metabotropic glutamate receptors.
Alexander GM; Godwin DW
J Neurophysiol; 2005 Jul; 94(1):163-75. PubMed ID: 15772234
[TBL] [Abstract][Full Text] [Related]
34. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
Fell MJ; Svensson KA; Johnson BG; Schoepp DD
J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
[TBL] [Abstract][Full Text] [Related]
35. Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia.
Lindsley CW; Shipe WD; Wolkenberg SE; Theberge CR; Williams DL; Sur C; Kinney GG
Curr Top Med Chem; 2006; 6(8):771-85. PubMed ID: 16719816
[TBL] [Abstract][Full Text] [Related]
36. Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine.
Baker DA; Madayag A; Kristiansen LV; Meador-Woodruff JH; Haroutunian V; Raju I
Neuropsychopharmacology; 2008 Jun; 33(7):1760-72. PubMed ID: 17728701
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
[TBL] [Abstract][Full Text] [Related]
38. Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors.
Brody SA; Dulawa SC; Conquet F; Geyer MA
Mol Psychiatry; 2004 Jan; 9(1):35-41. PubMed ID: 14699440
[TBL] [Abstract][Full Text] [Related]
39. Amygdala group II mGluRs mediate the inhibitory effects of systemic group II mGluR activation on behavior and spinal neurons in a rat model of arthritis pain.
Mazzitelli M; Neugebauer V
Neuropharmacology; 2019 Nov; 158():107706. PubMed ID: 31306647
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
Semenova S; Geyer MA; Sutcliffe JG; Markou A; Hedlund PB
Biol Psychiatry; 2008 Jan; 63(1):98-105. PubMed ID: 17531208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
